Exhibit 99.1
BABCOCK & WILCOX ENTERPRISES, INC.
INDEX TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
UNAUDITED PRO FORMA FINANCIAL INFORMATION
The following unaudited pro forma condensed consolidated financial information, which is based upon estimates by our management, is presented for informational purposes only. It is not intended to be indicative of the actual consolidated results of operations or the actual consolidated financial position that would have been achieved had the transactions or adjustments been consummated as of the dates indicated below, and it does not purport to indicate results that may be attained in the future.
BABCOCK & WILCOX ENTERPRISES, INC.
INDEX TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
| | PAGE |
| Unaudited Pro Forma Condensed Consolidated Balance Sheet as of June 30, 2024 | 3 |
| Unaudited Pro Forma Condensed Consolidated Statement of Operations for the Six Months Ended June 30, 2024 | 4 |
| Unaudited Pro Forma Condensed Consolidated Statement of Operations for the Year Ended December 31, 2023 | 5 |
| Notes to the Pro Forma Condensed Consolidated Balance Sheet as of June 30, 2024 | 6 |
| Notes to the Pro Forma Condensed Consolidated Statements of Operations for the Six Months Ended June 30, 2024 and the Year Ended December 31, 2023 | 6 |
BABCOCK & WILCOX ENTERPRISES, INC.
INDEX TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
On October 30, 2024, Babcock & Wilcox Enterprises, Inc. (the “Company”), through B&W PGG Luxembourg Finance Sárl and Babcock & Wilcox A/S, each a subsidiary of the Company (the “Seller”), closed its previously-disclosed sale of the entire issued and outstanding share capital of its (i) Italian subsidiary SPIG S.p.A. (“SPIG”), and, indirectly, its subsidiaries, and (ii) Swedish subsidiary Babcock & Wilcox Vølund AB f/k/a Götaverken Miljö AB (“GMAB”) to Auctus Neptune Holding S.p.A. (the “Buyer” and the agreement governing such sale, the “Purchase Agreement”).
The total base purchase price paid pursuant to the Purchase Agreement was approximately €36.7 million, subject to certain adjustments for specified indemnity obligations or specified payments, dividends, encumbrances, releases, share issuances or other payments made (or obligations assumed) by SPIG or GMAB, other than as permitted in the Purchase Agreement. The Purchase Agreement also provides for a three-year non-competition covenant limited to the Company’s continuing Wet and Dry Cooling Business and a three-year non-solicitation covenant.
The following unaudited pro forma condensed consolidated financial statements are based on our historical consolidated financial statements as adjusted to give effect to the sale of the SPIG and GMAB (“Divestiture Group”). The unaudited pro forma condensed consolidated statements of operations for the six months ended June 30, 2024 and the 12 months ended December 31, 2023 give effect to the sale as if it had occurred on January 1, 2023. The unaudited pro forma condensed consolidated balance sheet as of June 30, 2024 gives effect to the transaction as if it had occurred on that date.
The unaudited pro forma condensed consolidated financial statements are presented for illustrative purposes only and are not necessarily indicative of the operating results that would have occurred if the transactions actually occurred on the dates presented or to project our results of operations or financial position for any future period. The information below should be read in conjunction with the Company's consolidated financial statements as of and for six months ended June 30, 2024 and as of and for the year ended December 31, 2023.
BABCOCK & WILCOX ENTERPRISES, INC.
CONDENSED CONSOLIDATED BALANCE SHEET
JUNE 30, 2024
| (in thousands, except per share amounts) | | Company Historical | | | Divestiture Group Pro Forma Adjustments | | | Condensed Consolidated Pro Forma | |
| Cash and cash equivalents | | $ | 95,466 | | | $ | 26,174 | | | $ | 121,640 | |
| Current restricted cash and cash equivalents | | | 75,332 | | | | (1,766 | ) | | | 73,566 | |
| Accounts receivable – trade, net | | | 124,967 | | | | (25,076 | ) | | | 99,891 | |
| Accounts receivable – other | | | 25,945 | | | | (9,144 | ) | | | 16,801 | |
| Contracts in progress | | | 88,644 | | | | (22,078 | ) | | | 66,566 | |
| Inventories, net | | | 110,309 | | | | (3,644 | ) | | | 106,665 | |
| Other current assets | | | 24,958 | | | | (919 | ) | | | 24,039 | |
| Current assets held for sale | | | 28,941 | | | | — | | | | 28,941 | |
| Total current assets | | | 574,562 | | | | (36,453 | ) | | | 538,109 | |
| Net property, plant and equipment and finance leases | | | 78,168 | | | | (2,054 | ) | | | 76,114 | |
| Goodwill | | | 83,842 | | | | — | | | | 83,842 | |
| Intangible assets, net | | | 30,518 | | | | (8,826 | ) | | | 21,692 | |
| Right-of-use assets | | | 27,632 | | | | (723 | ) | | | 26,909 | |
| Long-term restricted cash | | | 31,291 | | | | — | | | | 31,291 | |
| Deferred tax assets | | | 2,094 | | | | — | | | | 2,094 | |
| Other assets | | | 21,015 | | | | (3,079 | ) | | | 17,936 | |
| Total assets | | $ | 849,122 | | | $ | (51,135 | ) | | $ | 797,987 | |
| | | | | | | | | | | | | |
| Accounts payable | | $ | 147,350 | | | $ | (25,559 | ) | | $ | 121,791 | |
| Accrued employee benefits | | | 11,850 | | | | (2,731 | ) | | | 9,119 | |
| Advance billings on contracts | | | 63,255 | | | | (11,135 | ) | | | 52,120 | |
| Accrued warranty expense | | | 6,695 | | | | (848 | ) | | | 5,847 | |
| Current Portion: | | | | | | | | | | | — | |
| Financing lease liabilities | | | 1,434 | | | | — | | | | 1,434 | |
| Operating lease liabilities | | | 3,532 | | | | (319 | ) | | | 3,213 | |
| Other accrued liabilities | | | 53,690 | | | | (951 | ) | | | 52,739 | |
| Loans payable | | | 3,475 | | | | — | | | | 3,475 | |
| Current liabilities held for sale | | | 42,609 | | | | — | | | | 42,609 | |
| Total current liabilities | | | 333,890 | | | | (41,543 | ) | | | 292,347 | |
| Senior notes | | | 339,024 | | | | — | | | | 339,024 | |
| Loans payable, net of current portion | | | 134,308 | | | | — | | | | 134,308 | |
| Pension and other postretirement benefit liabilities | | | 167,979 | | | | — | | | | 167,979 | |
| Finance lease liabilities, net of current portion | | | 25,465 | | | | — | | | | 25,465 | |
| Operating lease liabilities, net of current portion | | | 25,331 | | | | (404 | ) | | | 24,927 | |
| Deferred tax liability | | | 10,545 | | | | — | | | | 10,545 | |
| Other non-current liabilities | | | 10,924 | | | | (529 | ) | | | 10,395 | |
| Total liabilities | | | 1,047,466 | | | | (42,476 | ) | | | 1,004,990 | |
| | | | | | | | | | | | | |
| Stockholders' deficit: | | | | | | | | | | | | |
| Preferred stock, par value $0.01 per share, authorized shares of 20,000; issued and outstanding shares of 7,669 at both June 30, 2024 and December 31, 2023 | | | 77 | | | | — | | | | 77 | |
| Common stock, par value $0.01 per share, authorized shares of 500,000; issued and outstanding shares of 92,010 and 89,449 at June 30, 2024 and December 31, 2023, respectively | | | 5,174 | | | | — | | | | 5,174 | |
| Capital in excess of par value | | | 1,550,977 | | | | — | | | | 1,550,977 | |
| Treasury stock at cost, 2,154 and 2,139 shares at June 30, 2024 and December 31, 2023, respectively | | | (115,180 | ) | | | — | | | | (115,180 | ) |
| Accumulated deficit | | | (1,569,889 | ) | | | (8,659 | ) | | | (1,578,548 | ) |
| Accumulated other comprehensive loss | | | (70,088 | ) | | | — | | | | (70,088 | ) |
| Stockholders' deficit attributable to shareholders | | | (198,929 | ) | | | (8,659 | ) | | | (207,588 | ) |
| Non-controlling interest | | | 585 | | | | — | | | | 585 | |
| Total stockholders' deficit | | | (198,344 | ) | | | (8,659 | ) | | | (207,003 | ) |
| Total liabilities and stockholders' deficit | | $ | 849,122 | | | $ | (51,135 | ) | | $ | 797,987 | |
See accompanying Note to the Condensed Consolidated Balance Sheet
BABCOCK & WILCOX ENTERPRISES, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
FOR THE SIX MONTHS ENDED JUNE 30, 2024
| (in thousands, except per share amounts) | | Company Historical | | | Divestiture Group Pro Forma Adjustments | | | Condensed Consolidated Pro Forma | |
| Revenues | | $ | 441,198 | | | $ | (42,959 | ) | | $ | 398,239 | |
| Costs and expenses: | | | | | | | | | | | | |
| Cost of operations | | | 338,227 | | | | (43,310 | ) | | | 294,917 | |
| Selling, general and administrative expenses | | | 91,963 | | | | (6,657 | ) | | | 85,306 | |
| Restructuring activities | | | 2,347 | | | | (33 | ) | | | 2,314 | |
| Research and development costs | | | 2,261 | | | | (184 | ) | | | 2,077 | |
| Gain on sale of business | | | (40,174 | ) | | | — | | | | (40,174 | ) |
| (Gain) loss on asset disposals, net | | | 46 | | | | (47 | ) | | | (1 | ) |
| Total costs and expenses | | | 394,670 | | | | (50,231 | ) | | | 344,439 | |
| Operating income | | | 46,528 | | | | 7,272 | | | | 53,800 | |
| Other (expense) income: | | | | | | | | | | | | |
| Interest expense | | | (25,368 | ) | | | 44 | | | | (25,324 | ) |
| Interest income | | | 592 | | | | (51 | ) | | | 541 | |
| Loss on debt extinguishment | | | (6,124 | ) | | | — | | | | (6,124 | ) |
| Benefit plans, net | | | 188 | | | | — | | | | 188 | |
| Foreign exchange | | | (834 | ) | | | 387 | | | | (447 | ) |
| Other income (expense) – net | | | 426 | | | | 7 | | | | 433 | |
| Total other expense, net | | | (31,120 | ) | | | 387 | | | | (30,733 | ) |
| Income (loss) before income tax expense | | | 15,408 | | | | 7,659 | | | | 23,067 | |
| Income tax expense | | | 5,985 | | | | (793 | ) | | | 5,192 | |
| Income (loss) from continuing operations | | | 9,423 | | | | 8,452 | | | | 17,875 | |
| | | | | | | | | | | | | |
| Basic earnings (loss) per share | | | | | | | | | | | | |
| Continuing operations | | $ | 0.02 | | | | | | | $ | 0.12 | |
| | | | | | | | | | | | | |
| Diluted earnings (loss) per share | | | | | | | | | | | | |
| Continuing operations | | $ | 0.02 | | | | | | | $ | 0.12 | |
| | | | | | | | | | | | | |
| Shares used in the computation of basic earnings per share | | | 90,264 | | | | | | | | 90,264 | |
| Shares used in the computation of diluted earnings per share | | | 90,324 | | | | | | | | 90,324 | |
See accompanying Note to the Condensed Consolidated Statement of Operations
BABCOCK & WILCOX ENTERPRISES, INC.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
FOR YEAR ENDED DECEMBER 31, 2023
| (in thousands, except per share amounts) | | Company Historical | | | Divestiture Group Pro Forma Adjustments | | | Condensed Consolidated Pro Forma | |
| Revenues | | $ | 999,354 | | | $ | (94,272 | ) | | $ | 905,082 | |
| Costs and expenses: | | | | | | | | | | | | |
| Cost of operations | | | 775,267 | | | | (92,001 | ) | | | 683,266 | |
| Selling, general and administrative expenses | | | 191,465 | | | | (13,228 | ) | | | 178,237 | |
| Restructuring activities | | | 4,222 | | | | (77 | ) | | | 4,145 | |
| Research and development costs | | | 8,444 | | | | (433 | ) | | | 8,011 | |
| Impairment of assets | | | — | | | | 8,659 | | | | 8,659 | |
| Loss on asset disposals, net | | | 57 | | | | (1 | ) | | | 56 | |
| Total costs and expenses | | | 979,455 | | | | (97,081 | ) | | | 882,374 | |
| Operating income | | | 19,899 | | | | 2,809 | | | | 22,708 | |
| Other (expense) income: | | | | | | | | | | | | |
| Interest expense | | | (49,895 | ) | | | 501 | | | | (49,394 | ) |
| Interest income | | | 1,192 | | | | (90 | ) | | | 1,102 | |
| Benefit plans, net | | | (37,505 | ) | | | — | | | | (37,505 | ) |
| Foreign exchange | | | (2,507 | ) | | | 712 | | | | (1,795 | ) |
| Other expense – net | | | (1,336 | ) | | | (32 | ) | | | (1,368 | ) |
| Total other expense, net | | | (90,051 | ) | | | 1,091 | | | | (88,960 | ) |
| Income (loss) before income tax expense | | | (70,152 | ) | | | 3,900 | | | | (66,252 | ) |
| Income tax expense | | | 8,481 | | | | (1,252 | ) | | | 7,229 | |
| Income (loss) from continuing operations | | | (78,633 | ) | | | 5,152 | | | | (73,481 | ) |
| | | | | | | | | | | | | |
| Basic and diluted loss per share | | | | | | | | | | | | |
| Continuing operations | | $ | (1.05 | ) | | | | | | $ | (0.99 | ) |
| | | | | | | | | | | | | |
| Shares used in the computation of basic and diluted loss per share | | | 89,011 | | | | | | | | 89,011 | |
See accompanying Note to the Condensed Consolidated Statement of Operations
NOTE TO THE PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET AS OF JUNE 30, 2024
The balance sheet of the Company as of June 30, 2024 reflected the assets and liabilities of Babcock & Wilcox Enterprises, Inc. and the assets and liabilities of the Divestiture Group. Upon completion of the transaction, substantially all of the Divestiture Group assets and liabilities will be eliminated. Included in the Pro Forma Adjustments column are the divested assets and liabilities, the costs and expenses to be paid at closing and the estimated net cash proceeds from the transaction. Also included in the Pro Forma Adjustments is an increase in retained deficit that would have resulted from the loss on the sale of the business.
NOTE TO THE PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND THE YEAR ENDED DECEMBER 31, 2023
The statements of operations for the six months ended June 30, 2024 and year ended December 31, 2023 reflected the revenue, costs and other income (expenses) of the Company. Upon completion of the transaction with the Buyer, substantially all of the revenue, costs and other income (expenses) associated with Divestiture Group will be eliminated, except for those costs and other income (expense) related to retained assets and liabilities not assumed by the Buyer. As a result of this disposition, management determined that the divestiture group was not recoverable and accordingly recorded an impairment of $8.7 million on certain intangible assets in the year ended December 31, 2023.
The Pro Forma Condensed Consolidated Statement of Operations were prepared to eliminate income and expenses based on the following assumptions:
| · | All revenue and cost of sales of Divestiture Group will be eliminated with these transactions. |
| · | All selling, general and administrative expenses, research and development costs and corporate allocations of Divestiture Group will be eliminated with the exception of corporate allocations. |
| · | All other income (expense) items of Divestiture Group will be eliminated. |
| · | The loss on the sale of the Divestiture Group business was included in the year ended December 31, 2023. |
